Prescient Therapeutics Ltd
ASX:PTX

Watchlist Manager
Prescient Therapeutics Ltd Logo
Prescient Therapeutics Ltd
ASX:PTX
Watchlist
Price: 0.087 AUD -1.14% Market Closed
Market Cap: 91.5m AUD

Intrinsic Value

The intrinsic value of one PTX stock under the Base Case scenario is 0.002 AUD. Compared to the current market price of 0.087 AUD, Prescient Therapeutics Ltd is Overvalued by 97%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PTX Intrinsic Value
0.002 AUD
Overvaluation 97%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Prescient Therapeutics Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about PTX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PTX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Prescient Therapeutics Ltd.

Explain Valuation
Compare PTX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PTX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Prescient Therapeutics Ltd

Current Assets 12.9m
Cash & Short-Term Investments 6.9m
Receivables 4.9m
Other Current Assets 1.1m
Non-Current Assets 1.7m
PP&E 7.4k
Intangibles 1.7m
Other Non-Current Assets -100
Current Liabilities 3.2m
Accounts Payable 3.1m
Accrued Liabilities 67.5k
Other Current Liabilities -100
Non-Current Liabilities 13.5k
Other Non-Current Liabilities 13.5k
Efficiency

Free Cash Flow Analysis
Prescient Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Prescient Therapeutics Ltd

Revenue
225.6k AUD
Operating Expenses
-7.5m AUD
Operating Income
-7.3m AUD
Other Expenses
-12.3k AUD
Net Income
-7.3m AUD
Fundamental Scores

PTX Profitability Score
Profitability Due Diligence

Prescient Therapeutics Ltd's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

11/100
Profitability
Score

Prescient Therapeutics Ltd's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

PTX Solvency Score
Solvency Due Diligence

Prescient Therapeutics Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Long-Term Solvency
Low D/E
73/100
Solvency
Score

Prescient Therapeutics Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PTX Price Targets Summary
Prescient Therapeutics Ltd

There are no price targets for PTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PTX stock?

The intrinsic value of one PTX stock under the Base Case scenario is 0.002 AUD.

Is PTX stock undervalued or overvalued?

Compared to the current market price of 0.087 AUD, Prescient Therapeutics Ltd is Overvalued by 97%.

Back to Top